Bei Akademie registrieren
Evotec SE, DE0005664809

Evotec stock gets bullish HC Wainwright target hike

Published on 11/07/2026 at 12:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec stock drew a higher target from HC Wainwright after the company reported a sharper quarterly improvement. Full-year guidance remained unchanged.

Week brings analyst and earnings signals

  • HC Wainwright raised its Evotec price target and maintained a Buy rating.
  • Third-quarter adjusted EBITDA improved sharply, while nine-month revenue remained below the prior-year level.
  • Evotec kept its full-year 2026 outlook unchanged after the quarterly update.
Evotec SE, DE0005664809, Illustration mit AI erstellt.
Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec drew a more constructive analyst signal during the week after reporting a mixed third-quarter update. On Friday, November 6, 2026, HC Wainwright raised its price target to 5 US dollars from 4 US dollars and maintained a Buy rating, according to MarketBeat.

Quarterly improvement meets weaker nine months

Evotec reported third-quarter revenue of 164.9 million euros, broadly unchanged from the prior-year quarter. Adjusted EBITDA improved to a loss of 1.6 million euros from a loss of 15 million euros, a sharp improvement in quarterly profitability.

The nine-month picture was less favorable. Revenue fell to 465.0 million euros from 535.1 million euros in the prior-year period, while adjusted EBITDA declined to a loss of 44.3 million euros from a loss of 16.9 million euros. MarketBeat said the results beat estimates and noted that the company reaffirmed its 2026 guidance.

Guidance remains the next test

Evotec kept its full-year revenue outlook at 570 million to 610 million euros and its adjusted EBITDA outlook at a loss of 70 million to 105 million euros. The combination of improving quarterly profitability and weaker cumulative revenue leaves execution and the pace of the recovery central for investors.

Evotec stock traded at 3.14 euros on Lang & Schwarz at 12:26 CET on Saturday, November 7, 2026. Investors can follow the real-time quote of Evotec stock.

Evotec company facts

  • Company: Evotec SE
  • ISIN: DE0005664809
  • Latest quote: 3.14 euros on Lang & Schwarz, Saturday, November 7, 2026, 12:26 CET
  • Industry: Biotechnology

German large-cap market developments are covered in the DAX market overview.

For more company-specific coverage, see More news and analyses on Evotec stock.

Disclaimer...
en | DE0005664809 | EVOTEC SE | boerse | 70474272 |